People: MicroMed Cardiovascular Inc (MMCO.PK)

MMCO.PK on OTC Markets Group - US Other OTC and Grey Market

6,400.00USD
26 Oct 2011
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$6,400.00
Open
--
Day's High
$6,400.00
Day's Low
$6,400.00
Volume
0
Avg. Vol
0
52-wk High
$8,000.00
52-wk Low
$3,200.00

Search Stocks

Summary

Name Age Since Current Position

Clifford Zur Nieden

44 2007 Chairman of the Board

Robert Benkowski

42 2007 Chief Executive Officer

Deanne Yartz

2007 Chief Financial Officer

Matthew Borenzweig

49 2006 Director

Norwick Goodspeed

62 2003 Director

Pamela Westbrook

2007 Director

Biographies

Name Description

Clifford Zur Nieden

Mr. Zur Nieden was named Interim Chief Executive Officer in September 2006. Mr. zur Nieden has been a director of MicroMed since July 2006. Mr. zur Nieden is a managing partner of Ceres Capital Inc. He is a board member of Dunstone Financial (USA), a provider of professional debt collection solutions established in 1999, and is a co-founder and has been a board member of Inaxio, an information technology services company in Switzerland and Romania, since 2004. Mr. zur Nieden was the logistics director of Carlsberg Switzerland, responsible for its restructuring and reorganization, from 2002 to 2003. He also worked as CEO for CoCap Offerings Inc., a private equity trading platform that was merged with a security broker in Switzerland, from 2000 to 2001. Before that, he spent five years with Siemens AG in Germany and the United States to setup the GSM mobile network for the U.S. markets and with Nestlé in Singapore as an engineer. Mr. zur Nieden holds a Master of Science in engineering from ETH Zurich (Swiss Federal Institute of Technology).

Robert Benkowski

Robert J. Benkowski was named the Chief Operating Officer in September 2006. Mr. Benkowski joined MicroMed Technology in August 1996 as its Director of Engineering and became its Vice President of Engineering in April 2000. In December 2005, Mr. Benkowski became Senior Vice President of Engineering and Operations. Mr. Benkowski’s background is in aerospace with an expertise in Computer Aided Design, Manufacturing and Engineering (CAD/CAM/CAE). He worked on the engineering of the B-1, C-17 and the CAD integration of the International Space Station. He began working on the DeBakey VAD project in 1990, first while working at NASA’s Johnson Space Center, then at Baylor College of Medicine as a member of Dr. DeBakey’s team. He is a co-inventor of the original NASA technology, our continuation-in-part patent, a pulsatile loop patent, a VAD controller patent, four suction detection and physiologic algorithm patent applications and a neonatal blood pump developed for another company. He has received numerous awards for his work in this area, including induction to the United States Space Foundation’s “Space Technology Hall of Fame,” the Sezai Innovative Research Award, Olsen-Medforte Clinical Award, and the NASA Commercial Invention of the Year award.

Deanne Yartz

Deanne Yartz was appointed as Chief Financial Officer of Micromed Cardiovascular, Inc effective October 8, 2007. Since 2003, Ms. Yartz served as a financial consultant with Sirius Solutions, LLP. From 1998 to 2003, Ms. Yartz was an independent consultant for various private and publicly traded companies. Prior to that, Ms. Yartz was the VP of Finance and Chief Financial Officer of WNS, Inc., from 1986 to 1998. Ms. Yartz holds a BBA degree from the University of Texas and is a Certified Public Accountant.

Matthew Borenzweig

Mr. Matthew Borenzweig has served as a director of MicroMed Cardiovascular Inc. Mr. Borenzweig was Senior VP, Sales and Marketing for CardioMEMs, Inc, a medical device company. From June 2000 to January 2006, he was with Medtronic Vascular where he was Vice-President of U.S. Endovascular sales, managing a 95-person sales force. Mr. Borenzweig has also held sales and sales management positions at AVE/Medtronic, Boston Scientific, C. R. Bard and Upjohn Pharmaceuticals.

Norwick Goodspeed

Mr. Goodspeed has served as a director of MicroMed since March 2003. Mr. Goodspeed is President and Chief Executive Officer of FlowCardia, Inc., where he has served since March 2004. From May 2000 to January 2004, he was President and Chief Executive Officer of TransVascular, Inc., an interventional cardiology company acquired by Medtronic, Inc. in September 2003. From June 1997 to May 2000, he was President and Chief Executive Officer of Ocular Sciences, a publicly traded contact lens manufacturer. Previously, Mr. Goodspeed served as President of McGaw Inc. (a manufacturer of I.V. Solutions and a subsidiary of Ivax) and President and Chief Executive Officer of Vical, Inc. (a gene therapy company). Earlier in his career, Mr. Goodspeed held executive positions with BOC Healthcare and Baxter. He holds an MBA degree from Stanford University and a BA from Yale University.

Pamela Westbrook

Ms. Pamela B. Westbrook was director of MicroMed Cardiovascular Inc. She is a financial executive with over 25 years experience, primarily in the medical device industry. From 1998 to 2006, she served as Vice President, Finance and Administration and Chief Financial Officer for Cyberonics, Inc. Prior to joining Cyberonics, Ms. Westbrook was CFO for Physicians Resource Group from April 1998 to October 1998. From 1986 to 1998, Ms. Westbrook held positions with SulzerMedica Ltd including Vice President of Finance, Vice President Controller, and as Director of Finance and General Accounting.

Basic Compensation

Options Compensation

Search Stocks